Closure of patent foramen ovale and prevention of recurrent thromboembolic events

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 1, 2014, Pages 164-

  Zhang, Busheng ^a   Zhou, Jingxin ^a   Zhao, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR PROCEDURE; CEREBROVASCULAR ACCIDENT; HEART SURGERY; HUMAN; INTERMETHOD COMPARISON; LETTER; META ANALYSIS (TOPIC); PATENT FORAMEN OVALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE; CEREBROVASCULAR DISORDERS; FORAMEN OVALE, PATENT;

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ANTICOAGULANTS; CEREBROVASCULAR DISORDERS; FORAMEN OVALE, PATENT; HUMANS; PLATELET AGGREGATION INHIBITORS; THROMBOEMBOLISM;

EID: 84903529760     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25137     Document Type: Letter

References (2)

1. Pineda AM, Nascimento FO, Yang S, Kirtane A, Sommer R, Beohar N,. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events. Catheter Cardiovasc Interv 2013; 82: 968-975.
2. Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013; 368: 1092-1100.